3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Lung Neoplasms
4
Prostatic Neoplasms
3
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neurocognitive Disorders
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Immunoglobulin G4-Related Disease
1
Endometrial Neoplasms
1
Carcinoma, Renal Cell
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Autoimmune Pancreatitis
1
Anus Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anal Canal Carcinoma
1
Interventions
Magnetic Resonance Spectroscopy
13
Temozolomide
11
Specimen Handling
8
X-Rays
7
Biopsy
7
Nuclear Medicine Department, Hospital
6
Radiation
5
Phantoms, Imaging
5
erdafitinib
4
ulixertinib
3
trametinib
3
larotrectinib
3
dabrafenib
3
Radiotherapy
3
tipifarnib
2
selpercatinib
2
palbociclib
2
olaparib
2
ivosidenib
2
ensartinib
2
binimetinib
2
D2C7-(scdsFv)-PE38KDEL
2
vorasidenib
1
veliparib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
temsirolimus
1
tazemetostat
1
selinexor
1
sapanisertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioma
×
Observation
×
30 days
×
Clear all
No trials found.